BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1652309)

  • 1. Sensitive detection of clonal antigen receptor gene rearrangements for the diagnosis and monitoring of lymphoid neoplasms by a polymerase chain reaction-mediated ribonuclease protection assay.
    Veelken H; Tycko B; Sklar J
    Blood; 1991 Sep; 78(5):1318-26. PubMed ID: 1652309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of minimal residual disease in acute lymphoblastic leukemia using PCR-molecule hybridization of RNA transcripts].
    Liang X; Fei H; Xiao Y; Liu S; Yang A
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Jun; 15(3):164-6. PubMed ID: 9621126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of T-cell receptor gamma chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia.
    Taylor JJ; Rowe D; Williamson IK; Christmas SE; Proctor SJ; Middleton PG
    Blood; 1991 May; 77(9):1989-95. PubMed ID: 1850309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
    Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
    Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia.
    Taylor JJ; Rowe D; Kylefjord H; Chessells J; Katz F; Proctor SJ; Middleton PG
    Leukemia; 1994 Jan; 8(1):60-6. PubMed ID: 8289500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences.
    Greiner TC; Raffeld M; Lutz C; Dick F; Jaffe ES
    Am J Pathol; 1995 Jan; 146(1):46-55. PubMed ID: 7856738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antigen receptor gene rearrangements in lymphoproliferative malignancies by fluorescent polymerase chain reaction.
    Kerlan-Candon S; Soua Z; Lefranc MP; Clot J; Eliaou JF
    Tissue Antigens; 1998 Jan; 51(1):20-9. PubMed ID: 9459500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes.
    Jonsson OG; Kitchens RL; Scott FC; Smith RG
    Blood; 1990 Nov; 76(10):2072-9. PubMed ID: 2122920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection.
    Baruchel A; Cayuela JM; MacIntyre E; Berger R; Sigaux F
    Br J Haematol; 1995 May; 90(1):85-93. PubMed ID: 7786801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing.
    Kneba M; Bolz I; Linke B; Bertram J; Rothaupt D; Hiddemann W
    Blood; 1994 Jul; 84(2):574-81. PubMed ID: 8025283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis.
    Kneba M; Bolz I; Linke B; Hiddemann W
    Blood; 1995 Nov; 86(10):3930-7. PubMed ID: 7579363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias.
    d'Auriol L; Macintyre E; Galibert F; Sigaux F
    Leukemia; 1989 Feb; 3(2):155-8. PubMed ID: 2536129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease.
    Veelken H; Wood GS; Sklar J
    J Invest Dermatol; 1995 Jun; 104(6):889-94. PubMed ID: 7769255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioimmunoblastic lymphadenopathy with dysproteinemia and dermal T-cell lymphoma.
    Yu RC; Schofield J; Alaibac M; Jones RR; Chu AC
    Cancer; 1994 Sep; 74(6):1801-7. PubMed ID: 8082083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.